首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
【24h】

In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

机译:两性霉素B,伊曲康唑和伏立康唑对150株临床和环境烟曲霉菌株的体外活性。

获取原文
获取原文并翻译 | 示例
           

摘要

The in-vitro activity of amphotericin B, itraconazole and voriconazole against 130 clinical and 20 environmental Aspergillus fumigatus isolates was tested with an agar dilution method using RPMI 1640 medium. Itraconazole-susceptible (AF71) and -resistant (AF90) isolates were included in each test and all isolates were tested in duplicate. Geometric mean MIC values (ranges) at 48 h and 72 h were, respectively, amphotericin B, 0.91 (0.25-2) and 1.50 (1-4) mg/L; itraconazole, 0.25 (0.06-1) and 0.48 (0.125-8) mg/L; and voriconazole, 0.56 (0.25-8) and 0.78 (0.25-8) mg/L. The reproducibility of the results was high for all drugs. In-vitro resistance of A. fumigatus to the tested antifungal agents was uncommon and the MICs of itraconazole were half those of voriconazole (P < 0.01).
机译:使用琼脂稀释法,使用RPMI 1640培养基,测试了两性霉素B,伊曲康唑和伏立康唑对130份临床和20例环境烟曲霉菌株的体外活性。每次试验均包括对伊曲康唑敏感的(AF71)和耐药的(AF90)分离株,所有分离株均一式两份进行测试。 48 h和72 h的几何平均MIC值(范围)分别为两性霉素B,0.91(0.25-2)和1.50(1-4)mg / L;伊曲康唑0.25(0.06-1)和0.48(0.125-8)mg / L;伏立康唑为0.56(0.25-8)和0.78(0.25-8)mg / L。所有药物的结果重复性都很高。烟曲霉对测试的抗真菌剂的体外耐药性并不常见,伊曲康唑的MIC仅为伏立康唑的MIC的一半(P <0.01)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号